RIVN
Rivian Automotive, Inc.
RIVN lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
ZKH
ZKH Group Limited
There isn't enough reported data to score ZKH yet.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ZKH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Stable | |
| Unavailable |
ZKH's cash flow is currently stable, but its revenue and profitability are under pressure. There isn't enough data to rate its balance sheet.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
ZKH PE Valuation
ZKH has no meaningful PE right now: it lost money over the past year.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ZKH Forward outlook
There aren't enough analyst estimates for ZKH to show an outlook.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
ZKH Earnings Per Share
ZKH has the edge over RIVN in the latest year-over-year earnings comparison.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over ZKH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
ZKH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $365.7M | +12% |
| Q1 2026 | $317.2M | +9.2% |
| Q4 2025 | $383.8M | -70% |
| Q3 2025 | $349.4M | +2.1% |
| Q2 2025 | $325.2M | -3.7% |
| Q1 2025 | $290.4M | +4% |
| Q4 2024 | $1.3B | +245% |
| Q3 2024 | $342.3M | +0.7% |
ZKH's revenue is recovering but still below its 2024 peak: $366M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 0.2% | +3.5 points |
| Q1 2026 | -1.1% | +3.1 points |
| Q4 2025 | -1.1% | +2.7 points |
| Q3 2025 | -1.4% | +3.2 points |
| Q2 2025 | -3.3% | -0.1 points |
| Q1 2025 | -4.2% | +2.8 points |
| Q4 2024 | -3.8% | -3.6 points |
| Q3 2024 | -4.6% | +0.7 points |
ZKH has the edge over RIVN on profitability, with a higher operating margin.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has the edge over ZKH on cash flow, with more consistent year-over-year improvement.
ZKH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | +$12.5M |
| Q3 2024 | $0 | $0 |
ZKH's free cash flow was $0 over the past year, against $0 the year before.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
ZKH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -59K shares |
| 1 year | -1.6% | -72.8K shares |
| 3 years | +386% | +3.7M shares |
ZKH has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ZKH Net Leverage
ZKH's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
ZKH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 19.8 | Oversold |
| Stochastic | 6.5 | Oversold |
ZKH's weekly RSI is 20 (oversold) and its Stochastic is 7 (oversold).
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
ZKH PE vs Consumer Cyclical Sector
ZKH has no meaningful PE right now: it lost money over the past year.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
ZKH has stronger trend alignment. RIVN is above 0 of 5 weekly averages versus ZKH above 0 of 4.
ZKH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.91 | 33% below |
| 20 week MA | $2.48 | 48% below |
| 50 week MA | $2.88 | 56% below |
| 100 week MA | $3.02 | 58% below |
ZKH is in a downtrend: it's below all four of its weekly moving averages, and 58% below its 100-week average.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has the edge over ZKH on returns for 2026, with the stronger performance.
ZKH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $15.5 | $16.3 | +5.2% |
| 2024 | $16.3 | $3.35 | -79% |
| 2025 | $3.35 | $3.65 | +9% |
| 2026 YTD | $3.65 | $1.28 | -65% |
ZKH is down 65% so far in 2026, after finishing higher in two of the previous three years.